Comprehensive Addiction and Recovery Act (CARA) Local Drug Crises Grants
Comprehensive Addiction and Recovery Act (CARA) Local Drug Crises Grants provide funding to support current or former Drug-Free Communities recipients in efforts to prevent opioid, methamphetamine, and/or prescription drug use among youth ages 12-18. The program seeks to address the problem of substance use among youth by working with community leaders to identify local problems and implement evidence-based strategies designed to limit access to substances, change the culture/context around substance use, and create sustainable, community-level change.
Additional information on expected program strategies, activities, and short-term, intermediate, and long-term outcomes is available in the application instructions found on the related documents tab in the grants.gov funding announcement.
Applicants are encouraged to focus on underserved populations and those at higher risk of certain forms of substance abuse and misuse, including:
- Black and Hispanic youth
- LGBTQ youth
- Non-English speakers
- People with limited health literacy
- Tribal youth
- Youth in rural areas and other geographically underserved communities
Eligible applicants are community-based coalitions addressing opioid, methamphetamine and/or prescription drug use by local youth. Applicant organizations must be domestic, public or private nonprofit entities that are current or former recipients of a grant under the Drug-Free Communities (DFC) Act of 1997.
Applicants must also document rates of opioid or methamphetamine abuse at levels that are higher than the national average over a sustained period of time.
Award ceiling: $50,000 per year
Project period: 5 years
Estimated number of awards: 60
Estimated total program funding: $15,000,000
For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.